A novel mutation within intron 17 of the CUL7 gene results in appearance of premature termination codon
- 1 August 2020
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 507, 23-30
- https://doi.org/10.1016/j.cca.2020.04.008
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81501336)
- Henan Medical Science and Technology (2018020389, SB201901099)
This publication has 18 references indexed in Scilit:
- Clinical Utility Gene Card for: 3-M syndrome - Update 2013European Journal of Human Genetics, 2013
- Ubiquitination and Degradation of the Hominoid-Specific Oncoprotein TBC1D3 Is Mediated by CUL7 E3 LigasePLOS ONE, 2012
- The Genetics of 3-M Syndrome: Unravelling a Potential New Regulatory Growth PathwayHormone Research in Paediatrics, 2011
- 3M Syndrome: A Report of Four Cases in Two FamiliesJournal of Clinical Research in Pediatric Endocrinology, 2011
- A large-scale mutation search reveals genetic heterogeneity in 3M syndromeEuropean Journal of Human Genetics, 2008
- The CUL7 E3 Ubiquitin Ligase Targets Insulin Receptor Substrate 1 for Ubiquitin-Dependent DegradationMolecular Cell, 2008
- Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 functionOncogene, 2006
- Identification of mutations in CUL7 in 3-M syndromeNature Genetics, 2005
- Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesisProceedings of the National Academy of Sciences of the United States of America, 2003
- CUL7: A DOC domain-containing cullin selectively binds Skp1⋅Fbx29 to form an SCF-like complexProceedings of the National Academy of Sciences of the United States of America, 2002